Ono Pharmaceutical (OTCMKTS:OPHLF) Share Price Crosses Above Fifty Day Moving Average – What’s Next?

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF)’s share price crossed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $10.22 and traded as high as $11.19. Ono Pharmaceutical shares last traded at $11.19, with a volume of 4,180 shares changing hands.

Ono Pharmaceutical Price Performance

The company has a debt-to-equity ratio of 0.14, a current ratio of 3.55 and a quick ratio of 2.80. The firm has a market cap of $5.25 billion, a PE ratio of 10.75 and a beta of 0.74. The firm has a 50-day simple moving average of $10.22 and a 200 day simple moving average of $11.64.

Ono Pharmaceutical (OTCMKTS:OPHLF) last announced its quarterly earnings data on Monday, February 3rd. The company reported $0.21 EPS for the quarter. Ono Pharmaceutical had a return on equity of 9.10% and a net margin of 15.15%.

About Ono Pharmaceutical

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.